Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Roche Holding Ltd.    RHO5   CH0012032048

ROCHE HOLDING LTD.

 (RHO5)

3
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

N.J. Jury Orders Roche to Pay $18 Million to Former Accutane Users -Bloomberg

06/29/2012| 06:40pm US/Eastern
Recommend:
0

A New Jersey jury ordered Roche Holding AG (RHHBY) to pay two former users of its Accutane acne drug $18 million in damages, after finding the company didn't properly warn that the medicine could cause inflammatory bowel disease, Bloomberg News reported Friday.

Roche officials said the company will appeal the awards to Kathleen Rossitto and Riley Wilkinson, according to Bloomberg. The jury also rejected claims by two other former users of the drug, the report said.

"The company believes that the evidence at trial demonstrated that Accutane did not cause this disease and that Roche acted appropriately in providing information to the medical, scientific and regulatory communities," a Roche spokesman said in an emailed statement to Bloomberg.

Full story at http://www.bloomberg.com/news/2012-06-29/roche-ordered-to-pay-18-million-to-former-accutane-users.html

Write to nymonitoring@dowjones.com

Recommend :
0
Partner Area
React to this article
 
Latest news on ROCHE HOLDING LTD.
5d ago ROCHE HOLDING LTD.: Roche's obinutuzumab (GA101) significantly reduced the risk..
5d ago ROCHE HOLDING LTD.: Roche's obinutuzumab (GA101) significantly reduced the risk..
6d agoDJROCHE HOLDING LTD.: Roche Considers Sale of Blood Glucose Meter Unit -Reuters
6d agoDJPair of Studies Show Power of Immune System to Fight Cancer
6d ago ROCHE HOLDING LTD.: Genentech's Obinutuzumab (GA101) Significantly Reduced the ..
6d ago EXCLUSIVE: Roche exploring sale of diabetes device unit
6d ago ROCHE HOLDING LTD.: FDA approves Tarceva (erlotinib) tablets and cobas EGFR Mut..
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
6d ago ROCHE HOLDING LTD.: Roche to present important new data reflecting broad cancer..
Advertisement
Chart
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | RHO5 | CH0012032048 | 4-Traders
Income Statement Evolution
Roche Holding Ltd. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.